Dominance of cyclooxygenase-2 in the regulation of pancreatic islet prostaglandin synthesis

Diabetes

Volumn 47, Issue 9, 1998, Pages 1379-1383

  Paul Robertson, R ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b PACIFIC NORTHWEST RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTAGLANDIN SYNTHASE;

DIABETES MELLITUS; ENZYME ACTIVITY; ENZYME SYNTHESIS; HUMAN; INSULIN RELEASE; PANCREAS ISLET; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; REVIEW;

EID: 3543047940     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.47.9.1379     Document Type: Review

References (30)

1. Robertson RP: Molecular regulation of prostaglandin synthesis: implications for endocrine systems. Trends Endocrinol Metab 6:293-297, 1995
2. Rosen GD, Birkenmeier TH, Raz A, Holtzman JH: Identification of a cyclooxygenase-related gene and its potential role in prostaglandin formation. Biochem Biophys Res Commun 164:1358-1365, 1989
3. 2 synthase (cyclooxygenase) in human monocytes. J Biol Chem 265:16737-16740, 1990
4. Herschman HR: Prostaglandin synthase 2. Biochim Biophys Acta 1299:125-140, 1996
5. Wu KK, Sandjua R, Tsai A-L, Ferhanoglu B, Loose-Mitchell DS: Aspirin inhibits interleukin 1-induced prostaglandin H synthase expression in cultured endothelial cells. Proc Natl Acad Sci U S A 88:2384-2387, 1991
6. Crofford LJ, Wilder RL, Ristimaki AP, Sano H, Remmers EF, Epps HR, Hla T: Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues: effects of interleukin-1 beta, phorbol ester, and corticosteroids. J Clin Invest 93:1095-1101, 1994
7. Koehler L, Hass R, DeWitt DL, Resch K, Goppelt-Struebe M: Glucocorticoid-induced reduction of prostanoid synthesis in TPA-differentiated U937 cells is mainly due to a reduced cyclooxygenase activity. Biochem Pharmacol 40:1307-1316, 1990
8. Mitchell JA, Akarasereenont P, Thiemermann C, Flower RJ, Vane JR: Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci U S A 90:11693-11697, 1994
9. Kopp E, Ghosh S: Inhibition of NF-κB by sodium salicylate and aspirin. Science 265:956-959, 1994
10. Xie W, Merrill JR, Bradshaw WS, Simmons DL: Structural determination and promoter analysis of the chicken mitogen-inducible prostaglandin G/H synthase gene and genetic mapping of the murine homolog. Arch Biochem Biophys 300:247-252, 993
11. Kuehl F, Humes J: Direct evidence for a prostaglandin receptor and its application to prostaglandin measurements. Proc Natl Acad Sci U S A 69:480-484, 1972
12. Robertson RP: Characterization and regulation of prostaglandin and leukotriene receptors: an overview. Prostaglandins 3:395-411, 1986
13. Robertson RP, Seaquist ER, Walseth TF: G proteins and modulation of insulin secretion. Diabetes 40:1-6, 1991
14. 2 of a high-affinity GTPase in the secretory granules of normal rat and human pancreatic islets. Biochem J 297:399-406, 1994
15. Negishi M, Sugimoto Y, Ichikawa A: Prostanoid receptors and their biological actions. Prog Lipid Res 32:417-434, 1993
16. Coleman RA, Smith WL, Narumiya S: International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev 46:205-229, 1994
17. 3 subtype: different COOH-terminal domains determine sensitivity to agonist-induced desensitization. J Biol Chem 268:9517-9521, 1993
18. 3 subtype. Biochem Biophys Res Commun 203:1897-1903, 1994
19. Namba T, Sugimoto Y, Negishi M, Irie A, Ushikubi F, Kakizuka A, Ito S, Ichikawa A, Narumiya S: Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity. Nature 365:166-170, 1993
20. 2 receptor. J Biol Chem 269:6163-6169, 1994
21. Sorli CH, Zhang, H-J, Armstrong MB, Rajotte RV, Maclouf J, Robertson RP: Basal expression of cyclooxygenase-2 and nuclear factor-interieukin 6 are dominant and coordinately regulated by interleukin 1 in the pancreatic islet. Proc Natl Acad Sci U S A 95:1788-1793, 1998
22. Yamagata K, Andreasson KI, Kaufmann WE, Barnes CA, Worley PF: Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron 11:371-386, 1993
23. Harris RC, McKanna JA, Akai Y, Jacobson HR, Dubois RN, Breyer MD: Cyclooxygenase-2 is associated with the macula dense of rat kidney and increases with salt restriction. J Clin Invest 94:2504-2510, 1994
24. Asano K, Lilly CM, Drazen JM: Prostaglandin G/H synthase-2 is the constitutive and dominant isoform in cultured human lung epithelial cells. Am J Physiol 271:L126-L131, 1996
25. 2α receptor expression by interleukin-1β in cultured human granulosa-luteal cells. Endocrinology 138:3638-3644, 1997
26. Kwon G, Corbett JA, Hauser S, Hill JR, Turk J, McDaniel ML: Evidence for involvement of the proteasome complex (26S) and NFκB in IL-1β-induced nitric oxide and prostaglandin production by rat islets and RINm5F cells. Diabetes 47:583-591, 1998
27. Turk J, Colca JR, Kotagal N, McDaniel ML: Arachidonic acid metabolism in isolated pancreatic islets. II. The effects of glucose and of inhibitors of arachidonate metabolism on insulin secretion and metabolite synthesis. Biochim Biophys Acta 794:125-136, 1984
28. Robertson RP, Gavareski DJ, Porte D Jr, Biermun EL: Inhibition of in vivo insulin secretion by prostaglandin E1. J Clin Invest 54:310-315, 1974
29. Robertson RP, Chen M: A role for prostaglandin E in defective insulin secretion and carbohydrate intolerance in diabetes mellitus. J Clin Invest 60:747-753, 1977
30. Robertson RP: Arachidonic acid metabolite regulation of insulin secretion. Diabetes Metab Rev 2:261-296, 1986